Article
Targeting MAPAKAP2(MK2) to combat inflammation by avoiding the differential regulation of…
medRxiv · 2022 · Rakesh Kumar Singh
Key facts
| Title | Targeting MAPAKAP2(MK2) to combat inflammation by avoiding the differential regulation of anti-inflammatory genes by p38 MAPK inhibitors |
|---|---|
| First author | Rakesh Kumar Singh |
| Journal | medRxiv |
| Published | Jul 18, 2022 |
| DOI | 10.1101/2022.07.17.500377 |
| Devices mentioned | 203580 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1